Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel - The Memorial Sloan-Kettering Cancer Center experience

By Dizon D.S.   Dupont J.   Anderson S.   Sabbatini P.   Hummer A.   Aghajanian C.   Spriggs D.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 584-590

Elsevier

Access to resources Recommend Favorite

Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer - Kattan MW, Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY. Curr Opin Urol 2003; 13:111-116

By Carroll P.R.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 484-485

Elsevier

Access to resources Recommend Favorite

Lifestyle modification in colorectal cancer patients: an integrative oncology approach

By Jafri Syed H   Mills Glenn  

Future Oncology, Vol. 9, Iss. 2, 2013-02 ,pp. : 207-218

Future Medicine

Access to resources Recommend Favorite

Trends in Prostate Cancer in the United States

By Brawley Otis W.  

Journal of the National Cancer Institute Monographs, Vol. 2012, Iss. 45, 2012-09 ,pp. : 152-156

Oxford University Press

Access to resources Recommend Favorite

Introduction to Section on Integrative Oncology

By Wesa Kathleen  

Current Treatment Options in Oncology, Vol. 11, Iss. 3-4, 2010-12 ,pp. : 70-72

Springer Publishing Company

Access to resources Recommend Favorite